Form 8-K - Current report:
SEC Accession No. 0001004878-14-000139
Filing Date
2014-04-15
Accepted
2014-04-14 20:54:53
Documents
8
Period of Report
2014-04-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K RE LAIDLAW AGREE form8klaidlaw4-14.txt 8-K 7707
2 EXH. 1.1 - UNDERWRITING AGREE form8klaidlawexh1april-14.txt EX-1 136161
3 EXH. 5 - OPINION OF H&H form8klaidlawexh5april-14.txt EX-5 3974
4 EXH. 10(KK) - UNDERWRITERS' WARRANT form8klaidlawexh10kk4-14.txt EX-10 28547
5 EXH. 10(LL) - WARRANT AGENT AGREE form8klaidlawexh10ll4-14.txt EX-10 120634
6 EXH. 23 - CONSENT OF H&H form8klaidlawexh23april-14.txt EX-23 997
7 EXH. 99.1 - PRESS RELEASE 4/11/14 RE PROP. PUB. OFFERING form8klaidlawexh9914-14.txt EX-99 5022
8 EXH. 99.2 - PRESS RELEASE 4/14/14 RE $10 MILL OFFERING form8klaidlawexh9924-14.txt EX-99 5461
  Complete submission text file 0001004878-14-000139.txt   309757
Mailing Address 8229 BOONE BLVD. SUITE 802 VIENNA VA 22182
Business Address 8229 BOONE BLVD . SUITE 802 VIENNA VA 22182 7035069460
CEL SCI CORP (Filer) CIK: 0000725363 (see all company filings)

EIN.: 840916344 | State of Incorp.: CO | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-11889 | Film No.: 14763551
SIC: 2836 Biological Products, (No Diagnostic Substances)